Proprio Vision

Overview
Next-gen Medical Devices?
Product stageSegments
Go-to-Market
?
Non-implantable surgical devices
?

Proprio is a surgical technology company based in Seattle that has developed an innovative system called Paradigm to revolutionize the way surgeons perform complex procedures. Paradigm utilizes cutting-edge technologies such as light field imaging, computer vision, machine learning, robotics, and augmented reality to provide surgeons with real-time, three-dimensional visualizations of the surgical field.

The system captures high-definition images of the operating area and fuses them with preoperative 3D scans of the patient's anatomy. This allows surgeons to visualize key structures, including those that are difficult or impossible to see with the naked eye, in an immersive 3D environment. The generated images adapt to shifts in the anatomy, updating in real-time, eliminating the need for repeated intraoperative scans and reducing radiation exposure.

Paradigm has been primarily tested for spinal and cranial surgeries, which are among the most complex and revenue-generating procedures for hospitals. The system aims to increase surgical accuracy, reduce complications and revisions, decrease operating room time, and improve overall patient outcomes. In April 2023, Proprio received 510(k) clearance from the US Food and Drug Administration (FDA) for Paradigm, paving the way for its commercial launch.

The company's technology also holds potential for surgical training and data collection. Paradigm can capture a wealth of data during procedures, enabling analysis and potential predictive capabilities to further enhance surgical techniques and outcomes.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
111 W John St Suite 308 Seattle WA USA
Founded year:
2016
Employees:
11-50
IPO status:
Private
Total funding:
USD 85.1 mn
Last Funding:
USD 43.0 mn (Series B; Jul 2023)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.